iCo Therapeutics iCo Therapeutics Inc.

  • Home
  • Corporate Overview
    • Overview
    • Corporate Video
    • Partnering Strategy
    • Management Team
    • Board of Directors
    • Strategic Advisory Board
    • Professional Advisors
  • Pipeline
    • iCo-007
    • Antisense Technology
    • iCo-008
    • iCo-009
    • Clinical Trials
  • Investor Relations
    • Overview
    • Press Releases
    • Media Coverage
    • Upcoming Events
  • Careers
    • About Vancouver
    • Current Opportunities
  • Contact Us

Investor Relations

Upcoming Events

BioFinance 2010
April 6 – 8, 2010
Andrew Rae presenting April 7, 2010
Toronto Ontario

ARVO – Association for Research in Vision and Ophthalmology
May 2 – 6, 2010
Fort Lauderdale, FL

Past Events

Angiogenesis, Exudation and Degeneration
February 20, 2010
Key Biscayne, FL

JP Morgan – 28th Annual JP Morgan Healthcare Conference
January 11 – 14, 2010
San Francisco, CA

ISOPT – The 8th International Symposium on Ocular Pharmacology and Therapeutics
December 3 – 6, 2009
Rome, Italy

American Academy of Ophthalmology (AAO) Annual Meeting
October 23-27, 2009
San Francisco, CA

Ophthalomology Innovation Summit
October 22nd, 2009
San Francisco, CA

BioPartnering Europe
October 11-14, 2009
London, UK

11th SoCalBio Investor and Partnership Conference
September 17, 2009
Los Angeles, California

Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
May 3-7, 2009
Fort Lauderdale, FL

BIO International Convention
May 18-19, 2009
Atlanta, GA

BioFinance
April 28 – 30, 2009
Toronto, ON
iCo presentation

Focus on Fungal Infections
March 4 – 6, 2009
Sanibel Island, FL

Keystone Symposium on Drug Discovery for Protozoan Parasites: Part of the Keystone Symposia Global Health Series, Supported by the Bill & Melinda Gates Foundation
March 22 – 26, 2009
Breckenridge, CO
iCo-009 presentation

Angiogenesis, Exudation and Degenerations, Bascom Palmer Eye Institute
February 21, 2009
Key Biscayne, FL
iCo-007 presentation

American Academy of Ophthalmology, Atlanta, GA
November 8-11, 2008

Rodman & Renshaw 10th Annual Healthcare Conference, New York, NY
November 10-12, 2008

BioContact Quebec, Quebec City, QC
October 1-3, 2008

BIO International Convention, San Diego, CA
June 17, 2008 – June 20, 2008

BioFinance, Toronto, ON
May 6-8, 2008

ARVO (Association for Research in Vision and Ophthalmology)
Fort Lauderdale, FL
April 27, 2008 – May 1, 2008

Rodman & Renshaw, Monte Carlo
May 19-20, 2008
Partnering for Global Health Forum, Washington, DC
March 10, 2008 – March 12, 2008

7th International Symposium on Ocular Pharmacology and Therapeutics, Budapest, Hungary
February 28, 2008 – March 2, 2008
Dr. Peter Hnik presenting “iCo-007, a VEGF “+” Agent for the Potential Treatment of Diabetic Macular Edema and Diabetic Retinopathy”, date and time to be announced.

BIO Asia Partnering Conference 2008, Tokyo, Japan
January 28, 2008 to January 29, 2008

Angiogenesis
February 23-24, 2007
Key Biscayne, FL, USA

DIA Oligo-based Therapeutic Conference
April 19-20, 2007, Bethesda, MD, USA

Retina Summit Karlsruhe
December 2, 2006, Karlsruhe, Germany

Rodman & Renshaw 8th Annual Healthcare Conference
November 7, 2006, New York, New York

2nd Annual Meeting of the Oligonucleotide Therapeutics Society
October 19-21, 2006, Rockefeller University, New York, New York

BioContact Quebec
October 5, 2006, Quebec City, Quebec

EPIC
June 22, 2006, London, UK

BIO InvestorForum
October 20, 2005, San Francisco, California

BioFinance Early Phase 2005
November 16, 2005, Toronto, Ontario

BioPartnering North America
February 5-7, 2006, Vancouver, British Columbia

Invest Northwest
March 21-22, 2006, Seattle, Washington

IBC’s 3rd Annual Conference on Ocular Anti-angiogenesis
March 29-30, 2006 Cambridge, Massachusetts

BIO (Business Forum)
April 9-12, 2006 Chicago, Illinois

BioFinance
May 2-4, 2006 Toronto, Ontario

C21 Bioventures
May 23-25, 2006 Monterey, California

image

Investor & Media Contact

John Meekison
Chief Financial Officer
604.602.9414

.(JavaScript must be enabled to view this email address)

Contact Us

Items with an asterisk * are required







What is one hundred plus one? (Type in the number)

  • Home
  • Corporate Overview
  • Pipeline
  • Investor Relations
  • Careers
  • Contact Us

Copyright © 2005 iCo Therapeutics Inc. All rights reserved. Terms of Use.